Volume | 878,787 |
|
|||||
News | - | ||||||
Day High | 22.30 | Low High |
|||||
Day Low | 21.695 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Rocket Pharmaceuticals Inc | RCKT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
22.19 | 21.695 | 22.30 | 21.98 | 22.10 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,776 | 878,787 | $ 21.98 | $ 19,319,979 | - | 14.89 - 32.525 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:47:44 | 35 | $ 21.9794 | USD |
Rocket Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.05M | 90.50M | - | 0 | -245.6M | -2.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Rocket Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RCKT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 23.29 | 24.76 | 21.695 | 23.08 | 771,921 | -1.34 | -5.75% |
1 Month | 26.99 | 26.99 | 21.695 | 24.25 | 681,332 | -5.04 | -18.67% |
3 Months | 28.66 | 31.47 | 21.695 | 27.16 | 739,718 | -6.71 | -23.41% |
6 Months | 18.07 | 32.525 | 17.52 | 26.07 | 799,382 | 3.88 | 21.47% |
1 Year | 17.76 | 32.525 | 14.89 | 22.88 | 874,393 | 4.19 | 23.59% |
3 Years | 45.08 | 49.66 | 7.565 | 21.30 | 742,448 | -23.13 | -51.31% |
5 Years | 18.67 | 67.48 | 7.565 | 23.41 | 595,401 | 3.28 | 17.57% |
Rocket Pharmaceuticals Description
Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. |